On this week’s Spoon Podcast, SuperGut CEO Marc Washington joins me to talk about why new GLP-1 drugs like Ozempic and Wegovy keep CPG brand CEOs up at night.
These new drugs, which got their start as a new class of pharmaceuticals that help control type 2 diabetes, have become very popular in recent years as weight loss miracle drug. They are hugely effective in suppressing appetites and reducing the overall calorie intake of those taking them, so much so that some speculate that they could have a significant impact on the overall demand for food if, as predicted, tens of millions begin to take them in coming years as prices come down and they become available in more accessible formats.
Marc’s company, SuperGut, creates a natural alternative to GLP-1 drugs in the form of supplements, snacks and bars. His journey to become CEO of SuperGut was born out of a personal loss and a chance meeting with Dave Friedberg, the CEO of The Production Board.
You can listen to our conversation by clicking below, downloading to your device, or heading over to Apple Podcasts, Spotify or wherever you listen to podcasts.